Stent Fracture after Everolimus-Eluting Stent Implantation
Compared with bare-metal stents, drug-eluting stents (DES) have greatly reduced the risk of in-stent restenosis (ISR) by inhibiting neointimal growth. Nevertheless, DES are still prone to device failure, which may lead to cardiac events. Recently, stent fracture (SF) has emerged as a potential mecha...
Saved in:
Main Authors: | Ali S. Almasood, Xavier Freixa, Sohail Q. Khan, Peter H. Seidelin, Vladimír Džavík |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.4061/2011/320983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
by: Daisuke Kitano, et al.
Published: (2025-03-01) -
In Stent Restenosis Predictors after Carotid Artery Stenting
by: Mirco Cosottini, et al.
Published: (2010-01-01) -
Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents
by: Amir F. Mohani, et al.
Published: (2018-01-01) -
Postoperative Endophthalmitis after Combined Cataract Extraction and iStent Inject Implantation
by: Johnson Huang, et al.
Published: (2023-01-01) -
Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
by: Zhi-Ming Jiang, et al.
Published: (2022-01-01)